{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T14:37:16Z","timestamp":1775227036056,"version":"3.50.1"},"reference-count":31,"publisher":"Baishideng Publishing Group Inc.","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2008]]},"DOI":"10.3748\/wjg.14.913","type":"journal-article","created":{"date-parts":[[2008,2,21]],"date-time":"2008-02-21T01:21:02Z","timestamp":1203556862000},"page":"913","source":"Crossref","is-referenced-by-count":21,"title":["Non-alcoholic fatty liver disease in the Philippines:Comparable with other nations?"],"prefix":"10.3748","volume":"14","author":[{"given":"Mark Anthony A","family":"De Lusong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Silverman JF, Pories WJ, Caro JF. Liver pathology in diabetes mellitus and morbid obesity. Clinical, pathological, and biochemical considerations. Pathol Annu 1989;24:275-302."},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-1219.","DOI":"10.1053\/jhep.2003.50193"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.","DOI":"10.1056\/NEJMra011775"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990;12:1106-1110.","DOI":"10.1002\/hep.1840120505"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis 2004;8:501-519, vii.","DOI":"10.1016\/j.cld.2004.04.008"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Angulo P. Treatment of nonalcoholic fatty liver disease. Ann Hepatol 2002;1:12-19.","DOI":"10.1016\/S1665-2681(19)32187-8"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Nair S, Diehl AM, Wiseman M, Farr GH Jr, Perrillo RP. Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial. Aliment Pharmacol Ther 2004;20:23-28.","DOI":"10.1111\/j.1365-2036.2004.02025.x"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Bugianesi E, Gentilcore E, Manini R, Natale S, Vanni E, Villanova N, David E, Rizzetto M, Marchesini G. A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease. Am J Gastroenterol 2005;100:1082-1090.","DOI":"10.1111\/j.1572-0241.2005.41583.x"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ueno T, Sugawara H, Sujaku K, Hashimoto O, Tsuji R, Tamaki S, Torimura T, Inuzuka S, Sata M, Tanikawa K. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997;27:103-107.","DOI":"10.1016\/S0168-8278(97)80287-5"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Hickman IJ, Jonsson JR, Prins JB, Ash S, Purdie DM, Clouston AD, Powell EE. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004;53:413-419.","DOI":"10.1136\/gut.2003.027581"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Cox KL, Burke V, Morton AR, Beilin LJ, Puddey IB. Independent and additive effects of energy restriction and exercise on glucose and insulin concentrations in sedentary overweight men. Am J Clin Nutr 2004;80:308-316.","DOI":"10.1093\/ajcn\/80.2.308"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Angulo P, Lindor KD. Treatment of nonalcoholic fatty liver: present and emerging therapies. Semin Liver Dis 2001;21:81-88.","DOI":"10.1055\/s-2001-12931"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Laurin J, Lindor KD, Crippin JS, Gossard A, Gores GJ, Ludwig J, Rakela J, McGill DB. Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study. Hepatology 1996;23:1464-1467.","DOI":"10.1002\/hep.510230624"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Promrat K, Lutchman G, Uwaifo GI, Freedman RJ, Soza A, Heller T, Doo E, Ghany M, Premkumar A, Park Y. A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis. Hepatology 2004;39:188-196.","DOI":"10.1002\/hep.20012"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Sanyal AJ, Mofrad PS, Contos MJ, Sargeant C, Luketic VA, Sterling RK, Stravitz RT, Shiffman ML, Clore J, Mills AS. A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 2004;2:1107-1115.","DOI":"10.1016\/S1542-3565(04)00457-4"},{"key":"ref16","unstructured":"Podolsky DK. Infiltrative, genetic and metabolic diseases affecting the liver. Harrison’s Principles of internal medicine. 15th ed New York: Mc Graw-Hill; 2001;1767-1768."},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002;346:1221-1231.","DOI":"10.1056\/NEJMra011775"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980;55:434-438.","DOI":"10.1016\/S0025-6196(24)00530-5"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I, Kusano Y. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci 1995;40:2002-2009.","DOI":"10.1007\/BF02208670"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Franzese A, Vajro P, Argenziano A, Puzziello A, Iannucci MP, Saviano MC, Brunetti F, Rubino A. Liver involvement in obese children. Ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Dig Dis Sci 1997;42:1428-1432.","DOI":"10.1023\/A:1018850223495"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Scatarige JC, Scott WW, Donovan PJ, Siegelman SS, Sanders RC. Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation. J Ultrasound Med 1984;3:9-14.","DOI":"10.7863\/jum.1984.3.1.9"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Saadeh S, Younossi ZM. The spectrum of nonalcoholic fatty liver disease: from steatosis to nonalcoholic steatohepatitis. Cleve Clin J Med 2000;67:96-97, 101-104.","DOI":"10.3949\/ccjm.67.2.96"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Bird GL, Williams R. Factors determining cirrhosis in alcoholic liver disease. Mol Aspects Med 1988;10:97-105.","DOI":"10.1016\/0098-2997(88)90017-9"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Basaranoglu M, Acbay O, Sonsuz A. A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis. J Hepatol 1999;31:384.","DOI":"10.1016\/S0168-8278(99)80243-8"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Lee RG. Nonalcoholic steatohepatitis: a study of 49 patients. Hum Pathol 1989;20:594-598.","DOI":"10.1016\/0046-8177(89)90249-9"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Powell EE, Cooksley WG, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology 1990;11:74-80.","DOI":"10.1002\/hep.1840110114"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994;107:1103-1109.","DOI":"10.1016\/0016-5085(94)90235-6"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Diehl AM, Goodman Z, Ishak KG. Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology 1988;95:1056-1062.","DOI":"10.1016\/0016-5085(88)90183-7"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419.","DOI":"10.1016\/S0016-5085(99)70506-8"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:17-26.","DOI":"10.1055\/s-2001-12926"},{"key":"ref31","unstructured":"Muhammad Khurram, Abdul Shakoor, Mian M Arshad, Hamama tul Bushra Khaar, Zubair Hasan. Characteristic features of 50 NAFLD patients New York: Mc Graw-Hill; 2004;DHQ Teaching Hospital Rawalpindi."}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T17:21:09Z","timestamp":1738084869000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/14\/913.asp"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":31,"journal-issue":{"issue":"06","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.14.913","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}